FIELD: biotechnology.
SUBSTANCE: claimed invention relates to bispecific binding proteins that bind two antigens and contain three polypeptide chains. The invention also relates to a pharmaceutical composition for the treatment or prevention of cancer associated with cMet and/or EGFR, and a method for the treatment or prevention of cancer using the above-mentioned composition.
EFFECT: obtaining a composition for the treatment of cancer.
6 cl, 18 ex, 42 dwg, 73 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TETRAVALENT SYMMETRICAL BISPECIFIC ANTIBODIES | 2019 |
|
RU2807346C2 |
| PSEUDO-FAB BASED MULTISPECIFIC BINDING PROTEINS | 2019 |
|
RU2820254C2 |
| RECOMBINANT CORYNEBACTERIUM GLUTAMICUM FOR EFFICIENT SYNTHESIS OF HIGHLY PURE HYALURONIC ACID AND OLIGOSACCHARIDES THEREOF | 2019 |
|
RU2823305C1 |
| HIGH-AFFINITY ANTI-PD-1 AND ANTI-LAG-3 ANTIBODIES AND BISPECIFIC BINDING PROTEINS OBTAINED FROM THEM | 2019 |
|
RU2782381C2 |
| IMMUNOGLOBULIN WITH TANDEM ARRANGEMENT OF FAB FRAGMENTS AND APPLICATION THEREOF | 2014 |
|
RU2769133C2 |
| EMBODIMENTS OF IGG-Fc FOR USE IN VETERINARY SCIENCE | 2018 |
|
RU2814952C2 |
| POLYVALENT AND POLYSPECIFIC OX40-BINDING FUSED PROTEINS | 2017 |
|
RU2773052C2 |
| IL-12 HETERODIMERIC FC FUSION PROTEINS | 2019 |
|
RU2819097C2 |
| POLYVALENT AND POLYSPECIFIC GITR-BINDING FUSED PROTEINS | 2016 |
|
RU2753439C2 |
| FUSED PROTEIN CONSTRUCTS FOR COMPLEMENT-RELATED DISEASE | 2019 |
|
RU2824402C2 |
